Infection Control

Top Story

AM-Pharma BV announces phase 2 trial results for sepsis treatment in patients with AKI

March 12, 2018

Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents

November 17, 2017
Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance imaging that may be safer for people with impaired kidney…

Collagen-based drug delivery system may improve AV fistula maturation rate

November 15, 2017
Preliminary results from a Phase 3 study suggest an investigational treatment approach may improve the maturation rate for arteriovenous (AV) fistula. At ASN’s…

Study shows genetic testing can help determine safest dose of warfarin

September 28, 2017
A new study finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint…
More Headlines »

Toward the Individualization of Treatment for Patients with Hyponatremia

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Hyponatremia is the most common electrolyte imbalance observed in patients, occurring in up to 30% of hospitalizations…
More »
PerspectiveOpen Access

Health Literacy and Medication Management in Chronic Kidney Disease

HLRP: Health Literacy Research and Practice, Summer 2017, Volume 1 Issue 3
Chronic kidney disease (CKD) is the progressive decline of kidney function, which may eventually lead to kidney failure…
More »

Pain Management Update

No commercial support for this activity.

This course is designed to provide healthcare professionals with information on pain including the physiology and types…
More »
Meeting News Coverage

VIDEO: Giullian discusses goals of incident dialysis alternative payment model

March 16, 2018
More »